Ionis analyst coverage
WebWith RNA as the basis of our discovery platform, we are able to bring therapeutic options to patients who otherwise would have none. Our antisense therapies are … Web20 mrt. 2024 · Ionis Pharmaceuticals (NASDAQ:IONS) Now Covered by Analysts at StockNews.com Posted by MarketBeat News on Mar 20th, 2024 StockNews.com started …
Ionis analyst coverage
Did you know?
Web11 apr. 2024 · Ulz covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Zentalis Pharmaceuticals, and Karyopharm Therapeutics. The word on … Web12 apr. 2024 · Buy candidate since 2024-04-05 Gain 1.86% PDF. The Ionis Pharmaceuticals stock price gained 1.86% on the last trading day (Thursday, 6th Apr …
Web11 feb. 2024 · CARLSBAD, Calif., Feb. 11, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that the European Medicines Agency (EMA) has granted orphan drug designation to ION373 for the treatment of people with Alexander disease, a severe, progressive and debilitating … Web20 mrt. 2024 · Ionis Pharmaceuticals Price Performance. Shares of NASDAQ:IONS opened at $35.18 on Thursday. The company has a debt-to-equity ratio of 2.06, a quick ratio of …
Web12 apr. 2024 · UBS Group assumed coverage on shares of Capital Southwest (NASDAQ:CSWC – Get Rating) in a research note released on Tuesday, The Fly reports. The firm issued a neutral rating and a $19.00 target ... WebIonis Pharmaceuticals Stock (NASDAQ:IONS), Analyst Ratings, Price Targets, Predictions Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst …
WebOct 2014 - Apr 20246 years 7 months. Greater New York City Area. Led equity research team covering US Small & Mid-Cap Biotechnology …
WebAnalyst Coverage; Ownership Profile; Financials. SEC Filings; Annual Reports; Governance. Governance Documents; Committee Composition; Investor Resources. … great lakes safety productsWeb12 apr. 2024 · Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) last announced its earnings results on Wednesday, February 22nd.The company reported ($0.37) earnings … flocked christmas trees at michaelsWeb22 mrt. 2024 · Ionis Pharmaceuticals Price Performance. NASDAQ IONS opened at $35.62 on Tuesday. Ionis Pharmaceuticals has a fifty-two week low of $31.46 and a fifty-two … flocked christmas trees with led lightsWeb5 apr. 2024 · Benevolent AI made the unusual decision to try inhibiting tropomyosin receptor kinases (Trks), best known for their role in cancer, in atopic dermatitis, and today disclosed a failure. The topical project BEN-2293 was generated by the Benevolent Platform, the group’s AI-enabled drug discovery engine, to block Trks A, B and C. flocked christmas tree salesWebIonis Pharmaceuticals, Inc. (IONS) Analyst Ratings, Estimates & Forecasts - Yahoo Finance Finance Home My Portfolio Crypto Yahoo Finance Plus Personal Finance … great lakes safety services llcWebDMPK RESEARCH, DEVELOPMENT, OPTION AND LICENSE AGREEMENT . This DMPK RESEARCH, DEVELOPMENT, OPTION AND LICENSE AGREEMENT (the “Agreement”) is entered into as of the 27th day of June, 2012 (the “Effective Date”) by and between ISIS PHARMACEUTICALS, INC., a Delaware corporation, having its principal place of … flocked christmas trees michaelsWeb12 apr. 2024 · The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). Certara had a net margin of 4.39% and a return on equity of 5.97%. The business had... great lakes safety products leamington